Description
AZD8421 is an experimental drug currently being studied by AstraZeneca. It is being investigated in clinical trials for various advanced solid tumors, including colorectal cancer. The trials are in the early phase (Phase 1), primarily focused on determining the safety and tolerability of the drug, both when given alone and in combination with other cancer treatments. The goal of these early trials is to find the right dose and understand how the drug works in the body before moving to larger studies to test its effectiveness. The specific role of AZD8421 in colorectal cancer treatment is still under investigation.
Mechanism of Action
AZD8421 is a new drug, and its exact mechanism of action (how it works in the body to fight cancer) is still being studied. Clinical trials are evaluating its effects on cancer cells and how it interacts with other drugs. It is being tested alone and in combination with other targeted therapies.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.